Women in Science - Nuclear Medicine 2024

1,662
Total downloads
7,326
Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 09 Jul 2025

Affibody-based targeting agent 131I-YZHER2: V2 for HER2-positive ovarian cancer xenografts

Hongyu Hu
Xianwen Hu
Fangming Li
Guanlian Wang
Jiong Cai

doi 10.3389/fmed.2025.1507596

354 views

OPINION

Published on 09 Feb 2024

Gender and disease-inclusive nomenclature consolidation of theragnostic target, prostate-specific membrane antigen (PSMA) to folate hydrolase-1 (FOLH1)

Marigdalia K. Ramirez-Fort
Casey K. Gilman
Jacob S. Alexander
Barbara Meier-Schiesser
Arjan Gower
Mojtaba Olyaie
Neel Vaidya
Kiarash Vahidi
Yuxin Li
2 more
Corinne Deurdulian

doi 10.3389/fmed.2023.1304718

1,137 views

ORIGINAL RESEARCH

Published on 17 Jan 2024

Change of glucometabolic activity per PSMA expression predicts survival in mCRPC patients non-responding to PSMA radioligand therapy: introducing a novel dual imaging biomarker

Caroline Burgard
Jakob Engler
Arne Blickle
Mark Bartholomä
Stephan Maus
Andrea Schaefer-Schuler
Fadi Khreish
Samer Ezziddin
Florian Rosar

doi 10.3389/fmed.2023.1339160

1,749 views
2 citations

ORIGINAL RESEARCH

Published on 25 Jul 2023

ATN profile classification across two independent prospective cohorts

Débora E. Peretti
Federica Ribaldi
Max Scheffler
Linjing Mu
Valerie Treyer
Anton F. Gietl
Christoph Hock
Giovanni B. Frisoni
Valentina Garibotto

doi 10.3389/fmed.2023.1168470

2,104 views
1 citation

Share on

Frontiers in Medicine

Frontiers in Medicine

Nuclear Medicine

Impact

7,326Topic views
4,865Article views
1,662Article downloads